Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v10-EN | Version v8-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2022-07-14 | 2022-07-13 |
| Drug Identification Number | 00392693 | 00392693 |
| Brand name | ATROPINE SULFATE INJECTION USP | ATROPINE SULFATE INJECTION USP |
| Common or Proper name | ATROPINE SO4 | ATROPINE SO4 |
| Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
| Ingredients | ATROPINE SULFATE | ATROPINE SULFATE |
| Strength(s) | .6MG | .6MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 1ML 10LIAM | 1ML 10LIAM |
| ATC code | A03BA | A03BA |
| ATC description | BELLADONNAAND DERIVATIVES, PLAIN | BELLADONNAAND DERIVATIVES, PLAIN |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2022-04-20 | 2022-04-20 |
| Actual start date | ||
| Estimated end date | 2022-07-08 | 2022-07-08 |
| Actual end date | 2022-07-13 | 2022-07-13 |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Product is available on allocation at wholesalers, based on 100% of historical volumes. | Product is available on allocation at wholesalers, based on 100% of historical volumes. |
| Health Canada comments |